Abstract
Roux-en-Y gastric bypass (RYGB) surgery is more effective than nonsurgical treatments of obesity to sustain long-term weight loss. During the RYGB procedure, the stomach is divided into an upper gastric pouch, which is 15–30 mL in volume, and a lower gastric remnant. The gastric pouch is anastomosed to the jejunum after it has been divided some 30–75 cm distal to the ligament of Treitz; this distal part is brought up as a “Roux limb.” The excluded biliary limb, including the gastric remnant, is connected to the bowel 75–150 cm distal to the gastrojejunostomy.
The outcomes following RYGB vary between patients, and predicting individual outcomes is difficult. In this chapter, each outcome is reviewed individually and the controversies that surround it are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.
Dixon JB, Schachter LM, O’Brien PE, Jones K, Grima M, Lambert G, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308(11):1142–9.
Bjorklund P, Laurenius A, Een E, Olbers T, Lonroth H, Fandriks L. Is the Roux limb a determinant for meal size after gastric bypass surgery? Obes Surg. 2010;20(10):1408–14.
Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93(2):210–5.
Mathes CM, Spector AC. Food selection and taste changes in humans after Roux-en-Y gastric bypass surgery: a direct-measures approach. Physiol Behav. 2012;107(4):476–83.
Werling M, Olbers T, Fandriks L, Bueter M, Lonroth H, Stenlof K, et al. Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-y gastric bypass compared to vertical banded gastroplasty. PLoS One. 2013;8(4):e60280.
Buse JB, Caprio S, Cefalu WT, Ceriello A, Del PS, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.
Zimmet P, Alberti KG, Rubino F, Dixon JB. IDF’s view of bariatric surgery in type 2 diabetes. Lancet. 2011;378(9786):108–10.
Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966–71.
Cremieux PY, Ghosh A, Yang HE, Buessing M, Buchwald H, Shikora SA. Return on investment for bariatric surgery. Am J Manag Care. 2008;14(11):e5–6.
Maciejewski ML, Livingston EH, Smith VA, Kahwati LC, Henderson WG, Arterburn DE. Health expenditures among high-risk patients after gastric bypass and matched controls. Arch Surg. 2012;147(7):633–40.
Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31(8):1248–61.
Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.
Svensson PA, Anveden A, Romeo S, Peltonen M, Ahlin S, Burza MA, et al. Alcohol consumption and alcohol problems after bariatric surgery in the swedish obese subjects study. Obesity (Silver Spring). 2013 Mar 21. doi: 10.1002/oby.20397 [Epub ahead of print].
Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.
Miras AD, Chuah LL, Lascaratos G, Faruq S, Mohite AA, Shah PR, et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care. 2012;35(12):e81.
Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;(1):CD007340.
Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med. 2002;162(18):2061–9.
Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.
Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
le Roux, C.W. (2014). The Controversies Around Roux-en-Y Gastric Bypass. In: Haslam, D., Sharma, A., le Roux, C. (eds) Controversies in Obesity. Springer, London. https://doi.org/10.1007/978-1-4471-2834-2_31
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2834-2_31
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2833-5
Online ISBN: 978-1-4471-2834-2
eBook Packages: MedicineMedicine (R0)